Semaglutide product-specific bioequivalence guidance - Scientific guideline

Scientific guidelineHumanScientific guidelines

Swedish is available via eTranslation, the European Commission's machine translation service.

Translate to Swedish | Important information about machine translation

Semaglutide tablet 1.5, 4, 9, 25 and 50 mg product-specific bioequivalence guidance

Keywords: Bioequivalence, generics, semaglutide

Open consultation

Semaglutide tablet 1.5, 4, 9, 25 and 50 mg product-specific bioequivalence guidance

Draft: consultation open Consultation dates: to Reference Number: EMA/198690/2026 Summary:

Comments should be provided using this EUSurvey form. For any technical issues, please contact the EUSurvey Support.

English (EN) (142.38 KB - PDF)

Först publicerad:
Visa

Share this page